Phillips-Medisize Corporation announced the appointment of Iran Bateman to the position of Vice President, Engineering Europe. In this role, Mr. Bateman will join the senior pre-production management team in Europe where he will lead the strategy implementation, as well as the European pre-production engineering organization.
“We are pleased to have Iran join the Phillips-Medisize team with nearly 30 years of experience in the drug
delivery device segment providing contract design, development and manufacturing services to pharmaceutical
companies. Iran brings vast knowledge and leadership experience of complex teams – B2B commercial
management and business development, leading the development of operations and pre-production
capabilities, scaling up and supporting customer launches of complex drug delivery devices and development,”
said Matt Jennings, Chairman and CEO of Phillips-Medisize.
In commenting on his new position, Mr. Bateman said, “I am extremely excited about my appointment and the
opportunity this affords me to lead the pre-production activities in Europe while delivering on the existing
program commitments. I look forward to expanding the capabilities we offer in Europe, by leveraging our U.S.
capabilities to better service our global customers’ needs in Europe. Phillips-Medisize’s capabilities are truly
unique and an exception to others in the industry. It is a great pleasure to be a part of this market leading team.”
Mr. Bateman comes to Phillips-Medisize from Tech Group / West Pharmaceutical Services where during his 10
years he held roles encompassing Product Development, NPI and Operations leadership. Prior to joining Tech
Group in 2005, Mr. Bateman was Founder and Managing Director of EMS Ltd, a consultancy company to
support the industrialization of drug delivery devices. Mr. Bateman spent over 6 years in Consort/Bespak Plc
where he held leadership positions spanning account management and business development to program
management and site leadership.
Mr. Bateman has an Honours degree in Mechanical Engineering from the University of Portsmouth, UK and a
DMS from Warwick Business School, UK.
In addition to Mr. Bateman, Phillips-Medisize has hired several other experienced individuals featuring
backgrounds with industry leaders such as Novo Nordisk, Eli Lilly, Quest Diagnostics, Baxter, and Alcon. These
investments represent a continued commitment to grow our pre-production services and expertise, and are part
of the ongoing strategy to grow both organically and through acquisition.